Enhanced Smoking Cessation for University Students

NCT ID: NCT00941395

Last Updated: 2018-11-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

39 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-06-30

Study Completion Date

2017-06-08

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This trial studies how well a new smoking cessation and prevention intervention works in enhancing smoking cessation for university students. The new intervention may be easier to use for students to quit smoke.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

PRIMARY OBJECTIVES:

I. To establish the feasibility of a new smoking cessation and prevention intervention including two new modules addressing alcohol use and depression.

II. Demonstrate the feasibility of a smoking prevention website.

OUTLINE: Participants are assigned to 1 of 2 arms.

ARM I: Participants who currently smoke complete a survey over 30 minutes and discuss the survey results with the counselor over 30 minutes at week 2. Participants also complete 3 internet surveys over 20 minutes.

ARM II: Participants who currently do not smoke complete a survey over 30 minutes and discuss the survey results with the counselor over 30 minutes at week 2.

After completion of study, participants are followed up at 3 months.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cigarette Smoker Current Every Day Smoker

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Arm I (smoker, survey)

Participants who currently smoke complete a survey over 30 minutes and discuss the survey results with the counselor over 30 minutes at week 2. Participants also complete 3 internet surveys over 20 minutes.

Group Type EXPERIMENTAL

Survey Administration

Intervention Type OTHER

Complete surveys

Arm II (non-smoker, survey)

Participants who currently do not smoke complete a survey over 30 minutes and discuss the survey results with the counselor over 30 minutes at week 2.

Group Type EXPERIMENTAL

Survey Administration

Intervention Type OTHER

Complete surveys

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Survey Administration

Complete surveys

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* CESSATION ARM: Student at University of Houston Central Campus or Texas A\&M University
* CESSATION ARM: Smoke 1 or more cigarettes a day
* CESSATION ARM: Speak and read English
* CESSATION ARM: Signed informed consent and an acknowledgement of participation requirements
* CESSATION ARM: Be enrolled in at least one class at respective campus at baseline
* CESSATION ARM: Provide current contact information
* CESSATION ARM: Have access to the Internet
* PREVENTION ARM: Student at University of Houston Central Campus or Texas A\&M University
* PREVENTION ARM: Speak and read English
* PREVENTION ARM: Signed Informed Consent and an acknowledgement of participation requirements
* PREVENTION ARM: Be enrolled in at least one class at respective campus at baseline
* PREVENTION ARM: Provide current contact information
* PREVENTION ARM: Have access to the Internet
* PREVENTION ARM: Evidence of smoking susceptibility (as defined by the Smoking Susceptibility Scale)
* CESSATION ARM: Willing to answer all survey questions on all survey instruments throughout the duration of study
* PREVENTION ARM: Willing to answer all survey questions on all survey instruments throughout the duration of study

Exclusion Criteria

* CESSATION ARM: Evidence of major depressive disorder (as defined by PHQ-9 \[Patient Health Questionnaire-9\])
* CESSATION ARM: Evidence of severe alcohol abuse (as defined by AUDIT \[Alcohol Use Disorders Identification Test\] measure)
* PREVENTION ARM: Current tobacco use
* PREVENTION ARM: Does not plan to continue as a student at their campus for at least one more year
* CESSATION ARM: Does not plan to continue as a student at their campus for at least one more year
* PREVENTION ARM: Evidence of major depressive disorder (as defined by PHQ-9 \[Patient Health Questionnaire-9\])
* PREVENTION ARM: Evidence of severe alcohol abuse (as defined by AUDIT measure)
* CESSATION ARM: Pregnancy
Minimum Eligible Age

18 Years

Maximum Eligible Age

35 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Cancer Institute (NCI)

NIH

Sponsor Role collaborator

M.D. Anderson Cancer Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Alexander Prokhorov

Role: PRINCIPAL_INVESTIGATOR

M.D. Anderson Cancer Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Texas A&M

College Station, Texas, United States

Site Status

M D Anderson Cancer Center

Houston, Texas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Related Links

Access external resources that provide additional context or updates about the study.

http://www.mdanderson.org

MD Anderson Cancer Center Website

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NCI-2018-02552

Identifier Type: REGISTRY

Identifier Source: secondary_id

2009-0351

Identifier Type: OTHER

Identifier Source: secondary_id

P30CA016672

Identifier Type: NIH

Identifier Source: secondary_id

View Link

R01CA069425

Identifier Type: NIH

Identifier Source: secondary_id

View Link

2009-0351

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Exercise, Smoking Cessation and Adolescents
NCT00297440 UNKNOWN PHASE1/PHASE2
Extended Cessation Treatment for Teen Smokers
NCT00459953 COMPLETED PHASE2/PHASE3
OCAST Cessation Study
NCT01921439 COMPLETED NA